Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population
10.3m
GDP (2003)
€265.8bn
Health expenditure
Health expenditure as proportion of GDP
Size of pharmaceutical market (2003)
Proportion of GDP spent on pharmaceuticals
Pharmaceutical Expenditure per capita (PPP)
Pharmaceutical market growth rate (2003)
Local currency
Euro (€)
Summary: Belgium
Belgium traditionally had a very bureaucratic system of registration and reimbursement, however, new rules have reformed the reimbursement decision-making process, which have made it simpler and brought approvals in line with EC timelines. Pressure on the healthcare budget more than likely means cost-containment measures in the pharmaceutical sector.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
11/10/2005
Industry complains about 2006 pharmaceutical budget
15/06/2005
Campaign launched against the misuse of antibiotics
15/06/2005
Changes to the pricing mechanism in 2005
Related Items
The Pharmaceutical Pricing Compendium
brings together articles, by some of the most qualified and distinguished commentators on pharmaceutical pricing, that deliver clear information on the practical business issues that surround the subject.